Weakened malaria parasite vaccine passes early trial
by Press Release from Outbreak News Today on (#27WNT)
Results from a first-in-human phase 1 study reveal a weakened form of the malaria parasite safely activated strong immune responses in 10 healthy volunteers, whose antibodies completely protected mice from malaria infection. Scientists tamed the parasite by deleting three genes critical to liver infection, offering a promising whole parasite vaccine candidate to combat the disease. ["]
The post Weakened malaria parasite vaccine passes early trial appeared first on Outbreak News Today.